Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology.
| Author | |
|---|---|
| Abstract |
:
Binge-eating disorder (BED) is a common psychiatric condition with adverse psychological and metabolic consequences. Lisdexamfetamine (LDX) is the only approved BED drug treatment. New drugs to treat BED are urgently needed. |
| Year of Publication |
:
2021
|
| Journal |
:
Journal of psychopharmacology (Oxford, England)
|
| Number of Pages |
:
2698811211032475
|
| Date Published |
:
2021
|
| ISSN Number |
:
0269-8811
|
| URL |
:
https://journals.sagepub.com/doi/10.1177/02698811211032475?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
|
| DOI |
:
10.1177/02698811211032475
|
| Short Title |
:
J Psychopharmacol
|
| Download citation |
